Personalis (PSNL) Total Non-Current Liabilities (2018 - 2026)
Personalis (PSNL) posted quarterly Total Non-Current Liabilities of $70.1 million for Q1 2026, up 9.47% year-over-year from $64.0 million in Q1 2025, and down 2.0% quarter-over-quarter from $71.5 million in Q4 2025.
Personalis (PSNL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Personalis' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $70.1 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 9.47% year-over-year to $70.1 million; the TTM figure through Mar 2026 stood at $70.1 million (up 9.47% YoY), while the FY2025 annual figure was $71.5 million, up 8.31% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $70.1 million, down from $71.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $93.3 million in Q2 2022, with the low at $64.0 million in Q1 2025.
- The 5-year median for Total Non-Current Liabilities is $71.7 million (2024), against an average of $74.2 million.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities jumped 119.09% in 2022, then slipped 27.06% in 2024.
- Personalis' Total Non-Current Liabilities stood at $74.2 million in 2022, then rose by 22.01% to $90.5 million in 2023, then retreated by 27.06% to $66.0 million in 2024, then gained by 8.31% to $71.5 million in 2025, then retreated by 2.0% to $70.1 million in 2026.
- Business Quant data shows PSNL's Total Non-Current Liabilities at $70.1 million in Q1 2026, $71.5 million in Q4 2025, and $68.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Personalis | 1.78 Bn | 1.56 Bn | 4.74 Mn | 76.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.55 Mn |
| Mar 31, 2026 | 70.07 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Sep 30, 2025 | 68.81 Mn |
| Jun 30, 2025 | 65.11 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 66.01 Mn |
| Sep 30, 2024 | 72.01 Mn |
| Jun 30, 2024 | 71.72 Mn |
| Mar 31, 2024 | 71.56 Mn |
| Dec 31, 2023 | 90.50 Mn |
| Sep 30, 2023 | 71.64 Mn |
| Jun 30, 2023 | 68.92 Mn |
| Mar 31, 2023 | 74.45 Mn |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 75.09 Mn |
| Jun 30, 2022 | 93.34 Mn |
| Mar 31, 2022 | 92.21 Mn |
| Dec 31, 2021 | 84.11 Mn |
| Sep 30, 2021 | 79.38 Mn |